You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 22, 2024

LEVO-T Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Levo-t patents expire, and what generic alternatives are available?

Levo-t is a drug marketed by Cediprof Inc and is included in one NDA.

The generic ingredient in LEVO-T is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Levo-t

A generic version of LEVO-T was approved as levothyroxine sodium by MYLAN on June 5th, 2002.

  Try a Trial

US Patents and Regulatory Information for LEVO-T

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-001 Mar 1, 2002 AB1,AB2,AB3 RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-007 Mar 1, 2002 AB1,AB2,AB3 RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-004 Mar 1, 2002 AB1,AB2,AB3 RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-011 Mar 1, 2002 AB1,AB2,AB3 RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-012 Dec 8, 2003 AB1,AB2,AB3 RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for LEVO-T

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-009 Mar 1, 2002 ⤷  Try a Trial ⤷  Try a Trial
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-007 Mar 1, 2002 ⤷  Try a Trial ⤷  Try a Trial
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-003 Mar 1, 2002 ⤷  Try a Trial ⤷  Try a Trial
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-004 Mar 1, 2002 ⤷  Try a Trial ⤷  Try a Trial
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-001 Mar 1, 2002 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for LEVO-T

See the table below for patents covering LEVO-T around the world.

Country Patent Number Title Estimated Expiration
Japan 2003528931 ⤷  Try a Trial
Australia 2001252953 ⤷  Try a Trial
European Patent Office 1267999 ⤷  Try a Trial
Israel 152024 PHARMACEUTICAL COMPOSITIONS CONTAINING THYROID HORMONE AND PROCESSES FOR THE MANUFACTURE THEREOF ⤷  Try a Trial
World Intellectual Property Organization (WIPO) 0174448 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.